ArticleGlycobiology2026
Semantic annotation of Glycomics and Glycoproteomics methods.
Article in Glycobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glycomics and glycoproteomics represent the systematic exploration of glycan structures and glycoprotein compositions within biological systems, aiming to elucidate their roles in physiological and pathological processes, including cancer, inflammation and infectious diseases. To support this investigation, glycomics and glycoproteomics utilize a diverse array of methodologies from molecular biology, biochemistry, analytical chemistry and bioinformatics. In this study, we investigated the semantic representation experimental workflows in glycomics and glycoproteomics publications through graph-based annotation using combination of existing domain-relevant ontologies. Rather than adhering to evolving metadata standards, this investigation explored a broad spectrum of biomedical and analytical ontologies to identify optimal annotations for the generative (e.g. sample preparation and derivatization) and transformative (e.g. separation and detection) phases of the workflow. The results show that integrating several ontologies yields more precise annotations than relying on a single one. However, several challenges arose, particularly where methodological reporting lacked critical metadata, such as derivatization conditions or glycan release protocols. Furthermore, the annotations imply that methodologies in the glycomic and glycoproteomic fields are more complex, on average, than those in other scientific fields. The results suggests that, while some specific concepts are missing in the ontologies, a limited number of ontologies adequately encompass the majority of aspects related to glycomics and glycoproteomics experiments. These can serve as a foundation for community-wide metadata standards and direct future efforts to refine and expand the ontologies for glycoscience research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.